Stay up-to-date with the latest information from Quadriga
Press Releases
April 11, 2023
Quadriga BioSciences Announces Dosing of First Subject in Phase 2 Study Evaluating QBS72S For Brain Metastases of Breast Cancer
February 14, 2023
Quadriga BioSciences Announces Dosing of First Subject in Phase 2 Study Evaluating QBS72S For Glioblastoma
October 25, 2022
Quadriga BioSciences Announces Completion of Enrollment in Phase 1 Study of QBS72S for Solid Tumors
July 23, 2020
Quadriga Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
October 10, 2017
Quadriga Wins $2M Phase II SBIR Grant for the Treatment of Glioblastoma Multiforme